Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
OGE Energy
OGE
$9.65B
| $59.5M | 0.05% |
1,338,426
+55,326
| +4% | +$2.39M |
|
|
HPP
452
Hudson Pacific Properties
HPP
$765M
| $59.5M | 0.05% |
225,657
-52,757
| -19% | -$13M |
|
453
Accenture
ACN
$109B
| $59.4M | 0.05% |
282,100
+185,500
| +192% | +$36.2M |
|
454
Ultrapar
UGP
$6.3B
| $59.2M | 0.05% |
9,453,880
+878,600
| +10% | +$4.47M |
|
455
Flowers Foods
FLO
$1.5B
| $58.9M | 0.05% |
2,709,880
+282,997
| +12% | +$6.15M |
|
|
CSR
456
Centerspace
CSR
$925M
| $58.5M | 0.04% |
806,516
+127,820
| +19% | +$9.54M |
|
457
AGNC Investment
AGNC
$13B
| $58.5M | 0.04% |
+3,307,199
| New | +$56.3M |
|
|
CTXS
458
DELISTED
Citrix Systems Inc
CTXS
| $58.4M | 0.04% |
+526,890
| New | +$56.7M |
|
459
America Movil
AMX
$69.3B
| $58.4M | 0.04% |
3,647,573
+991,603
| +37% | +$15.5M |
|
460
Nabors Industries
NBR
$1.31B
| $58.4M | 0.04% |
405,252
+171,626
| +73% | +$18.1M |
|
|
P
461
Everpure Inc
P
$36.8B
| $58.2M | 0.04% |
3,400,200
-656,400
| -16% | -$11.6M |
|
|
LOGM
462
DELISTED
LogMein, Inc.
LOGM
| $58.1M | 0.04% |
677,212
-113,400
| -14% | -$8.41M |
|
463
Papa John's
PZZA
$788M
| $58M | 0.04% |
919,068
-225,600
| -20% | -$13.4M |
|
464
Unitil
UTL
$985M
| $58M | 0.04% |
937,600
+10,900
| +1% | +$674K |
|
|
ETFC
465
DELISTED
E*Trade Financial Corporation
ETFC
| $57.9M | 0.04% |
1,277,140
+796,100
| +165% | +$34M |
|
466
Howmet Aerospace
HWM
$113B
| $57.9M | 0.04% |
2,454,780
+538,291
| +28% | +$12M |
|
|
NEX
467
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $57.9M | 0.04% |
8,640,318
+5,406,595
| +167% | +$29.2M |
|
|
CATM
468
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $57.7M | 0.04% |
1,293,020
+233,820
| +22% | +$8.88M |
|
|
CKH
469
DELISTED
Seacor Holdings Inc.
CKH
| $57.7M | 0.04% |
1,336,496
+58,496
| +5% | +$2.56M |
|
470
National Healthcare
NHC
$3.44B
| $57.7M | 0.04% |
667,200
+9,600
| +1% | +$802K |
|
471
Kimco Realty
KIM
$16.2B
| $57.6M | 0.04% |
2,780,628
-360,673
| -11% | -$7.57M |
|
472
Becton Dickinson
BDX
$49.2B
| $57.5M | 0.04% |
+216,573
| New | +$54M |
|
473
W&T Offshore
WTI
$558M
| $57.4M | 0.04% |
10,331,810
+599,172
| +6% | +$2.67M |
|
|
KBAL
474
DELISTED
Kimball International
KBAL
| $57.2M | 0.04% |
2,768,276
+56,691
| +2% | +$1.17M |
|
475
American Eagle Outfitters
AEO
$2.75B
| $56.8M | 0.04% |
3,865,054
-1,592,200
| -29% | -$24.3M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.